🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 19 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/11/2008 | 29,51 | 29,68 | 28,21 | 28,60 | -3,17% | 4,98% | 12.403.394 |
| 31/10/2008 | 28,65 | 30,24 | 27,80 | 29,53 | +2,52% | 8,53% | 17.296.087 |
| 30/10/2008 | 28,00 | 29,38 | 28,00 | 28,81 | +5,27% | 4,94% | 16.199.355 |
| 29/10/2008 | 28,11 | 29,30 | 27,22 | 27,37 | -3,40% | 7,40% | 19.345.242 |
| 28/10/2008 | 25,67 | 28,53 | 24,90 | 28,33 | +10,70% | 14,13% | 24.089.223 |
| 27/10/2008 | 25,79 | 27,06 | 24,62 | 25,59 | -1,94% | 9,47% | 17.051.170 |
| 24/10/2008 | 25,30 | 26,95 | 25,25 | 26,10 | -5,20% | 6,71% | 18.036.604 |
| 23/10/2008 | 27,14 | 28,03 | 25,63 | 27,53 | +3,00% | 8,86% | 23.369.352 |
| 22/10/2008 | 27,77 | 28,54 | 26,24 | 26,73 | -6,54% | 8,28% | 21.661.636 |
| 21/10/2008 | 28,99 | 30,00 | 28,47 | 28,60 | -3,32% | 5,27% | 14.933.371 |
| 20/10/2008 | 27,92 | 29,88 | 27,32 | 29,58 | +8,77% | 9,16% | 28.478.981 |
| 17/10/2008 | 26,28 | 28,82 | 26,08 | 27,19 | +1,10% | 10,42% | 24.122.654 |
| 16/10/2008 | 26,01 | 27,00 | 24,43 | 26,90 | +6,14% | 9,90% | 20.571.926 |
| 15/10/2008 | 27,51 | 27,77 | 25,20 | 25,34 | -8,82% | 9,33% | 19.094.665 |
| 14/10/2008 | 29,89 | 29,99 | 26,87 | 27,80 | -0,99% | 10,44% | 20.725.248 |
| 13/10/2008 | 25,98 | 28,43 | 25,88 | 28,07 | +12,16% | 9,81% | 21.405.819 |
| 10/10/2008 | 24,10 | 27,02 | 22,56 | 25,03 | +0,08% | 18,53% | 40.341.398 |
| 09/10/2008 | 27,15 | 27,26 | 24,36 | 25,01 | -8,10% | 10,69% | 26.672.124 |
| 08/10/2008 | 27,27 | 28,56 | 26,73 | 27,21 | -1,38% | 6,72% | 23.559.250 |
| 07/10/2008 | 28,66 | 29,81 | 27,50 | 27,60 | -3,73% | 8,06% | 21.661.531 |
| 06/10/2008 | 29,86 | 30,80 | 27,71 | 28,66 | -5,48% | 10,35% | 24.766.126 |
| 03/10/2008 | 29,95 | 30,82 | 29,82 | 30,32 | +2,19% | 3,34% | 18.125.684 |
| 02/10/2008 | 30,28 | 30,97 | 29,64 | 29,68 | -3,08% | 4,41% | 18.309.608 |
| 01/10/2008 | 29,98 | 30,95 | 29,96 | 30,62 | +1,68% | 3,31% | 14.831.191 |
| 30/09/2008 | 29,53 | 30,33 | 29,36 | 30,11 | +4,02% | 3,30% | 15.752.174 |
| 29/09/2008 | 30,43 | 30,65 | 28,95 | 28,95 | -5,54% | 5,58% | 25.067.846 |
| 26/09/2008 | 30,56 | 31,13 | 30,34 | 30,65 | -0,77% | 2,56% | 13.415.343 |
| 25/09/2008 | 30,18 | 31,14 | 30,08 | 30,89 | +2,86% | 3,51% | 16.323.648 |
| 24/09/2008 | 29,35 | 30,27 | 29,29 | 30,03 | +2,34% | 3,32% | 11.903.079 |
| 23/09/2008 | 30,03 | 30,53 | 29,28 | 29,34 | -2,23% | 4,16% | 18.463.454 |